Paul A. Bell

Array ( [id] => 15204391 [patent_doc_number] => 20190364882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS [patent_app_type] => utility [patent_app_number] => 16/543229 [patent_app_country] => US [patent_app_date] => 2019-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16543229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15243381 [patent_doc_number] => 10507200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-12-17 [patent_title] => Therapeutics compositions containing harmine and isovanillin components, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/541695 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 585 [patent_figures_cnt] => 592 [patent_no_of_words] => 34808 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16541695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15381773 [patent_doc_number] => 10532043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/541626 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 585 [patent_figures_cnt] => 593 [patent_no_of_words] => 34830 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16541626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15571419 [patent_doc_number] => 10576067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/541665 [patent_app_country] => US [patent_app_date] => 2019-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 585 [patent_figures_cnt] => 593 [patent_no_of_words] => 34827 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16541665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15144877 [patent_doc_number] => 20190350916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND [patent_app_type] => utility [patent_app_number] => 16/525859 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15114353 [patent_doc_number] => 20190343809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => Ifetroban Treatment for Systemic Sclerosis [patent_app_type] => utility [patent_app_number] => 16/524116 [patent_app_country] => US [patent_app_date] => 2019-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16524116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16784934 [patent_doc_number] => 10987333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Methods and compositions for preventing and treating auditory dysfunctions [patent_app_type] => utility [patent_app_number] => 16/506904 [patent_app_country] => US [patent_app_date] => 2019-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 28602 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16506904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15083375 [patent_doc_number] => 20190336498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE [patent_app_type] => utility [patent_app_number] => 16/505203 [patent_app_country] => US [patent_app_date] => 2019-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15342371 [patent_doc_number] => 20200009077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES [patent_app_type] => utility [patent_app_number] => 16/502189 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15342373 [patent_doc_number] => 20200009078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => ORAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/502244 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17805705 [patent_doc_number] => 20220257540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/622152 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16197386 [patent_doc_number] => 10722522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Dosing regimen for sedation with CNS 7056 (remimazolam) [patent_app_type] => utility [patent_app_number] => 16/457387 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15370 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17148367 [patent_doc_number] => 11141418 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-10-12 [patent_title] => Methods and compositions for KRAS inhibitors [patent_app_type] => utility [patent_app_number] => 16/449785 [patent_app_country] => US [patent_app_date] => 2019-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 33531 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15320841 [patent_doc_number] => 20200000750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => Composition for Treating Acute and Chronic Pain [patent_app_type] => utility [patent_app_number] => 16/449676 [patent_app_country] => US [patent_app_date] => 2019-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16741992 [patent_doc_number] => 10966959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Use of a rotifer-derived compound and its analogs for preventing schistosomiasis [patent_app_type] => utility [patent_app_number] => 16/445766 [patent_app_country] => US [patent_app_date] => 2019-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 8239 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17220675 [patent_doc_number] => 11173158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-16 [patent_title] => Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same [patent_app_type] => utility [patent_app_number] => 16/444396 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11281 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17035036 [patent_doc_number] => 20210251994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS [patent_app_type] => utility [patent_app_number] => 17/252225 [patent_app_country] => US [patent_app_date] => 2019-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -89 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19624059 [patent_doc_number] => 12162863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Modulators of stimulator of interferon genes (STING) [patent_app_type] => utility [patent_app_number] => 17/251291 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53596 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15553213 [patent_doc_number] => 20200061018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE [patent_app_type] => utility [patent_app_number] => 16/439164 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14140 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14893747 [patent_doc_number] => 20190290639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/438956 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438956 [rel_patent_id] =>[rel_patent_doc_number] =>)